Delivery Order SPE2DB20D1109-SPE2DB24FN49D
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes treatment medication. The contract has a ceiling value of $1,686.35 and is a firm fixed-price delivery order, with a period of performance extending through June 24, 2025. The contract is not set-aside and is open for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract has a ceiling value of $1,083.90 and is a firm fixed-price contract. The period of performance extends to July 8, 2025. This contract is not a set-aside and was awarded through open competition. AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $15,909.65 and runs through October 29, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract has a ceiling value of $7,177.64 and a period of performance through April 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a ceiling value of $1,501.50 and a completion date of February 3, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract has a ceiling value of $3,033.24 and a period of performance through April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a firm fixed price of $3,055.56 and a performance period through May 13, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication. The delivery order has a ceiling value of $3,790.86 and a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, which are used to treat diabetes. The contract has a ceiling value of $34,673.82 and a period of performance through March 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to manage diabetes. The contract has a firm fixed price with a ceiling value of $5,462.19 and an ultimate completion date of February 7, 2025. The contract is not set aside for any specific...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN49DDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5ml, a prescription medication used in the treatment of diabetes. The contract has a firm fixed price ceiling value of $5,228.12 and a performance period through January 25, 2024. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/24/24 |